Be the new Senior Device Developer
In a biotech company bonding to discover, design and develop innovative peptide-based medicines.
Currently, we are looking for a new Senior Device Developer, who has the expertise of developing novel Drug delivery solutions. If this sounds like you, and you are ready to take on a broad area of responsibilities with an independent attitude, you are a match for us.
You will be part of the Zealand Pharma Device Development team of highly engaged and
competent colleagues and be reporting to the VP of Device Development. The job includes execution and documentation of device development activities as well as regulatory and manufacturing documentation for drug delivery devices.
The job includes extensive collaboration across the Zealand Pharma organization and includes close dialogue with our device development partners and contract manufacturing organizations. You will be a key contributor to making innovative drugs available to patients.
Responsibilities
The job will include development activities for drug delivery devices within all disciplines
of Design Control: Planning, Requirement management, development, Design outputs,
Design verification, Risk management and Design validation.
Candidate profile
The successful candidate will have most or all of the below qualifications:
- Degree in Life Sciences (e.g., Engineering, Biochemistry, Pharmaceutical Sciences, or a related field).
- Minimum 5+ years in medical device development.
- Experience in the medical device industry, particularly in:
- Design Control and Device Development in compliance with ISO 13485.
- Risk Management and Usability Engineering.
- Design Verification and Design Validation principles.
- Combination products development under FDA and EU MDR requirements.
- Strong international collaboration skills.
- Excellent communication skills in English (both verbal and written).
- Proactive mindset with the ability to plan, execute, and meet deadlines.
- Analytical skills to manage complex technical issues and data.
- Genuine interest in working in a dynamic environment.
Bonding to innovate
Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.
We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise.
We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.
The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.
Let’s bond and be bold
We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities
To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/
Interested? Please apply no later than January 22nd 2025 or as soon as possible. The applications will be reviewed as they come in.
For further information, please contact Lars Stenholt, lstenholt@zealandpharma.com or Mobile +45 50603783
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.
